Loading company…
Oniria Therapeutics develops drugs targeting persistent tumor cells that remain after conventional treatment.
Oniria Therapeutics is a biotechnology company developing drugs to eliminate persistent tumor cells that remain after conventional treatment. Founded in 2021, the company is based in Barcelona, Spain.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in